Treatment of potentially life-threatening enterovirus infections with pleconaril.
about
Enterovirus and parechovirus infection in children: a brief overviewReplication and Inhibitors of Enteroviruses and ParechovirusesAseptic Meningitis and Viral MyelitisPleconaril, a novel antipicornaviral agentCoxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in miceUpdate in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditionsManagement of Viral Central Nervous System Infections: A Primer for CliniciansIn vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.Animal models of enterovirus 71 infection: applications and limitations.Enteroviruses as a possible cause of hypertension, dilated cardiomyopathy (DCM) and hypertensive heart failure (HHF) in South western Nigeria.Quantitative PCR-enhanced immunoassay for measurement of enteroviral immunoglobulin M antibody and diagnosis of aseptic meningitis.Molecular approaches to detecting herpes simplex virus and enteroviruses in the central nervous system.Viral encephalitis in England, 1989-1998: what did we miss?Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCRHuman rhinoviruses.Fluoxetine is a potent inhibitor of coxsackievirus replication.Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication.Antifungal and antiviral chemotherapy.Enteroviral meningitis: natural history and outcome of pleconaril therapyCD40 ligand deficiency: neurologic sequelae with radiographic correlationRemission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulationCytolytic replication of echoviruses in colon cancer cell linesAntenatal diagnosis of intrauterine infection with coxsackievirus B3 associated with live birth.Antivirals and antiviral strategies.Molecular methods for diagnosis of viral encephalitisCoxsackievirus-induced myocarditis: new trends in treatment.The antiviral effect of jiadifenoic acids C against coxsackievirus B3.A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.High Frequency of Detection by PCR of Viral Nucleic Acid in The Blood of Infants Presenting with Clinical Myocarditis.Strategies to develop antivirals against enterovirus 71Molecular evidence of persistent echovirus 13 meningoencephalitis in a patient with relapsed lymphoma after an outbreak of meningitis in 2000.Clinical and diagnostic findings of an echovirus meningitis outbreak in the north west of England.Potential use of antiviral agents in polio eradication.Transgenic expression of the 3D polymerase inhibits Theiler's virus infection and demyelination.The need for treatment against human parechoviruses: how, why and when?A review on guidelines for management and treatment of common variable immunodeficiency.Enteroviral encephalitis in children: clinical features, pathophysiology, and treatment advances.Pharmacokinetic considerations in the use of antivirals in neonates.
P2860
Q26751373-3B966725-3C1E-4EC9-8F37-FF26D7B1F024Q26798463-39149951-7874-4ACB-91B9-C4BBE02911A6Q27489376-F65EDAC8-4184-4A43-BB3C-047C6F14EC14Q28182006-76A50B7A-8144-4A8F-BE34-E8F06F1B7032Q28203874-54F6A5FF-DD39-4ED1-A367-F1BF09A50BE2Q28240370-344FD8B5-0072-4565-A306-183F3BBFD2CBQ30145523-BC7C01CB-4CCE-4BCC-B673-07BC73956C79Q30448335-436CC972-B6BF-40A6-9F3A-43FB4B5A538BQ30448643-197AC08E-DB4A-4522-814D-BB17A0047B49Q33579809-5BF05DD4-6325-42AE-A4BF-F0AB522370C3Q33751633-59BC585C-D474-45C8-8D50-33B281501B0CQ33858781-A18B8EA9-0223-4A53-9866-BCB92EB4143CQ33961421-06872731-730D-4507-9F1C-091F67B8100CQ33984375-6536E120-07C7-4BD4-A408-1E3471055A29Q34201928-FAFE71B6-DF21-4450-A57E-88314CAD00CBQ34321393-292A8D73-5644-47EB-870C-88ED43E5797BQ34323429-138856B2-7773-40F5-86F2-E209C7DCBB10Q34443617-F8B572FB-EF42-46BF-AAF4-A31E4B9EA506Q34596364-7B2F485A-E2D2-4124-A3B0-F3F020CDEEFEQ34639628-2626DE02-9E33-456F-9F8C-1F1685D6A88DQ34721507-80B43609-0D2E-4A7E-8B06-78E1852396D8Q35088971-7BC45DD9-8D96-426E-BD6A-C17090A4D7C0Q35391084-DB39AF5C-656F-4AC7-9AEC-3DA7B2C0E11EQ35541517-4EB694E3-2FD7-44FD-80F9-94FE671BA9E9Q35614530-19D02CF1-955D-4705-95D1-BC2CDDD17D19Q35889586-4640579C-5064-4017-AFD8-DBA03CFBD972Q35920649-5A4105CB-7376-4548-B76A-5532FD8A5C08Q36233532-9BD22467-6D49-454A-B0CF-AB8A01F8D9CDQ36237575-C5EABE6D-699F-4B00-89B5-2BD2BCD8584FQ36612928-A8F78D1D-5999-45C4-93D3-F5B34D5B1F51Q36643037-27DE76F0-97FC-4794-8A77-6861B5443880Q36734771-6C37388F-5A77-4BDE-AA11-37426FF77E72Q36891864-534B6694-7FC7-4C03-AFB1-F8C63674E071Q36928256-1C86DE01-D743-4185-B3D1-473139EAF6BEQ36944919-7A824719-8387-42AF-A4A9-58E2B3EE4705Q37452057-6DBC7975-2C61-4A88-8B1B-700C9F841CEEQ37816394-6356C16B-BFEF-418F-8D11-27F8887C0318Q38111423-1183E7A8-BE3D-4115-84F7-FF7B8C810553Q38245116-2DD59221-4988-4F53-BB38-DF941E750FE8Q38624965-1B578B72-E98D-4134-9FBF-F240E9A158FE
P2860
Treatment of potentially life-threatening enterovirus infections with pleconaril.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Treatment of potentially life-threatening enterovirus infections with pleconaril.
@ast
Treatment of potentially life-threatening enterovirus infections with pleconaril.
@en
type
label
Treatment of potentially life-threatening enterovirus infections with pleconaril.
@ast
Treatment of potentially life-threatening enterovirus infections with pleconaril.
@en
prefLabel
Treatment of potentially life-threatening enterovirus infections with pleconaril.
@ast
Treatment of potentially life-threatening enterovirus infections with pleconaril.
@en
P2093
P2860
P356
P1476
Treatment of potentially life-threatening enterovirus infections with pleconaril.
@en
P2093
A D Webster
H A Rotbart
Pleconaril Treatment Registry Group
P2860
P304
P356
10.1086/318452
P407
P577
2001-01-15T00:00:00Z